Arcus Biosciences Inc. (RCUS)
NYSE · Healthcare
Arcus Biosciences Inc. Total Liabilities 2017–2025
Arcus Biosciences Inc. annual/quarterly total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Arcus Biosciences Inc. total liabilities for the quarter ending December 31, 2025 were 508.0M, a 23.61% decrease year-over-year.
- Arcus Biosciences Inc. total liabilities for 2025 were 508.0M, a 23.61% decrease from 2024.
- Arcus Biosciences Inc. total liabilities for 2024 were 665.0M, a 5.06% increase from 2023.
- Arcus Biosciences Inc. total liabilities for 2023 were 633.0M, a 7.99% decrease from 2022.
- Arcus Biosciences Inc. total liabilities for 2022 were 688.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Arcus Biosciences Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $508 |
| 2024 | $665 |
| 2023 | $633 |
| 2022 | $688 |
| 2021 | $750 |
| 2020 | $270 |
| 2019 | $39 |
| 2018 | $40 |
| 2017 | $37 |
| Arcus Biosciences Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $508 |
| 2024-12-31 | $665 |
| 2023-12-31 | $633 |
| 2022-12-31 | $688 |
| 2021-12-31 | $750 |
| 2020-12-31 | $270 |
| 2019-12-31 | $39 |
| 2018-12-31 | $40 |
| 2017-12-31 | $37 |
Arcus Biosciences Inc. Total Liabilities — FAQ
Arcus Biosciences Inc. (RCUS) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RCUS's total liabilities history?
The chart and table above show Arcus Biosciences Inc.'s total liabilities by year and by quarter, including the growth rate.